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Previous findings from our own laboratory have shown that the frequency of occurrence (i.e. the simple presence or absence) of the
3895bp mitochondrial DNA deletion is increased with increasing sun exposure. The present study has significantly extended this
work by developing, validating and then using a quantitative real-time PCR assay to investigate for the first time the actual level (as
opposed to the frequency of occurrence) of the 3895bp deletion in human skin from different sun-exposed body sites and tumours
from nonmelanoma skin cancer patients. We investigated the 3895bp deletion in 104 age-matched split human skin samples taken
from various sun-exposed sites defined as usually exposed (n¼60) and occasionally exposed (n¼44) when outdoors. The results
clearly show an increased level of the 3895bp deletion with increasing sun exposure. Specifically, there was a significantly higher level
of the deletion in the usually sun-exposed compared to the occasionally sun-exposed skin (P¼0.0009 for dermis, P¼0.008 for
epidermis; two-tailed t-test). Our study has also extended previous findings by showing that the level of the 3895bp deletion is
significantly higher in the dermis compared with the epidermis both in the occasionally sun-exposed samples (P¼0.0143) and in the
usually sun-exposed skin. (P¼0.0007).
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The incidence of nonmelanoma skin cancer (NMSC) is increasing
in populations of European origin (Severi and English, 2004), for
example, 1 million new cases diagnosed each year in the USA
(Wesson and Silverberg, 2003) and 75000 in the UK (figures
provided by Cancer Research UK). Nonmelanoma skin cancer
accounts for around 90% of skin cancers and consists of basal cell
and squamous cell carcinomas (BCC and SCC, respectively).
Ultraviolet radiation (UVR) is the major determinant of NMSC. It
is a significant factor in the generation of oxidative damage, which
can lead to DNA strand breaks and to the production of DNA
photoproducts such as thymidine dimers, which importantly
cannot be repaired in mitochondrial DNA (mtDNA) (Clayton
et al, 1974). In addition mtDNA is located in the matrix, which is in
close proximity to the inner membrane where reactive oxygen
species (ROS) are continually produced in the electron transport
chain. This along with the absence of protective histones makes
mtDNA a sensitive marker of UV-induced DNA damage compared
to nuclear DNA (LeDoux et al, 1993; Croteau and Bohr, 1997;
Pascucci et al, 1997; Sawyer and Van Houten, 1999; Birch-Machin,
2000). Finally, each cell can contain up to several thousand copies
of the mtDNA genome and mitochondria can, therefore, tolerate
very high levels (up to 90%) damaged mtDNA through comple-
mentation of the remaining wild-type (Chomyn et al, 1992; Sciacco
et al, 1994). Therefore, cells are able to accumulate photodamage
in mtDNA without compromising cell function.
To determine a reliable marker of cumulative UVR exposure in
human skin, our research group and others have examined the
novel idea of using mtDNA, rather than nuclear DNA, as a
biomarker of UV-induced DNA damage (Pang et al, 1994;
Berneburg et al, 1997; Birch-Machin et al, 1998; Birch-Machin,
2000). Furthermore, we and others have shown that mtDNA
deletions can be induced in cultured human skin cells by sub-
lethal repetitive doses of UVA (Berneburg et al, 1999; Krishnan
et al, 2004). In agreement with observations of mtDNA damage in
other tumours (Birch-Machin, 2006; Czarnecka et al, 2006; Parr
et al, 2006) we have previously identified somatic mtDNA changes
in human skin as a result of the first detailed study of mtDNA
damage in NMSC (Durham et al, 2002). Importantly, as a result of
this study, we identified a 3895bp mtDNA deletion which occurred
more frequently in usually sun-exposed skin as opposed to
occasionally sun-exposed skin (Harbottle et al, 2004; Krishnan
et al, 2004). This is important because the relative density of NMSC
is highest on body sites ‘usually’ exposed to the sun when outdoors
(such as scalp, face, neck and ears as defined by Armstrong, 2004)
compared to occasionally sun-exposed sites (such as shoulders,
back and chest as defined by Armstrong, 2004).
Our previous study (Krishnan et al, 2004) showed that the
frequency of occurrence of the 3895bp deletion in human skin
provides a potential biomarker for cumulative UV exposure in
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shuman skin. The study also claimed that possible applications of
this biomarker may in turn provide an early detection tool for
NMSC development as well as providing a method of monitoring
long-term safety of clinical UV phototherapy regimes. However, in
order for this type of study to progress and become a reality one
needs to be able to quantify the level of the 3895bp deletion rather
than simply determine the frequency of occurrence (i.e. presence
or absence) of the deletion as reported in our previous study
(Krishnan et al, 2004). This has relevance to mitochondrial
function because the regions that are deleted in the 3895bp
deletion are functionally important. The deleted region includes
the mtTF1 binding site in the D-loop to tRNA methionine and
deleted genes include 12s rRNA, 16s rRNA, ND1 as well as the
promoters for transcription of both the H and L strands. There are
several key questions, which remain unanswered by our previous
study. One notable question is whether the greater frequency of
occurrence in the dermis vs the epidermis is mirrored by a greater
actual level of damage in the dermis when mtDNA damage is also
present in the corresponding epidermis. A second important
question is whether there is a greater absolute level of the 3895bp
deletion in usually sun-exposed compared to occasionally sun-
exposed skin in addition to the greater frequency of occurrence
observed in our previous study. The present study seeks to
overcome this clear limitation by developing a quantitative and
reliable real-time PCR assay for the 3895bp deletion. Levels of the
3895bp deletion are then determined in tumour and perilesional
skin taken from NMSC patients as well as skin (including both
epidermis and dermis) taken from different sun-exposed body
sites.
MATERIALS AND METHODS
Human skin samples
Tumour and matched perilesional skin samples were taken with
informed consent from patients undergoing excision of a NMSC,
namely basal cell carcinoma (BCC) (n¼5, age range 55–89 years
(yrs), mean 78yrs) or a squamous cell carcinoma (SCC) (n¼5, age
range 70–87yrs, mean 78yrs) at the Outpatients Clinic, Royal
Victoria Infirmary, Newcastle, UK. For the sun exposure studies,
clinically normal perilesional skin was taken from body sites which
are ‘usually’ exposed to the sun when outdoors (such as scalp, face,
neck and ears) (epidermis n¼30, dermis n¼30, mean age
7s.e.m.¼70.4572.161) and body sites which are ‘occasionally’
exposed to the sun (shoulders, back and chest) (epidermis n¼22,
dermis n¼22, mean age 7s.e.m.¼63.7773.501). There are no
significant age differences between the usually and occasionally
sun-exposed groups (P¼0.1134): two-tailed t-test (Welch correc-
tion). For all perilesional skin samples, epidermis and dermis were
separated using 0.25% dispase at 41C overnight (Durham et al,
2003) and DNA was extracted using a Qiagen, DNeasy tissue
extraction kit. None of the patients used for this study suffered
from a mitochondrial myopathy or had a mtDNA associated
neurodegenerative disease.
PCR analysis
The PCR was carried out in a 25ml reaction containing 200ng
genomic DNA, 600nM of each primer, 250mM dNTPs, 0.6U per
reaction Amplitaq Gold DNA polymerase (Applied Biosystems,
Warrington, UK), GeneAmp buffer (containing, 100mM Tris-HCl,
pH 8.3, 500mM KCl, 15mM MgCl and 0.01% (wv
 1) gelatin). The
PCR primers L404 and H4676 (Table 1 and Figure 1) were designed
to anneal outside the 3895bp deletion. During DNA amplification
the short (30s) polymerase extension time did not permit
amplification of wild-type PCR products, allowing only amplifica-
tion of the shorter and deleted mtDNA fragments. The PCR
conditions were 941C for 10min, 35 cycles of 941C for 30s, 561C
for 30s, 721C for 30s and a final extension of 7min at 721C.
Amplification products were visualised in a 1% agarose gel stained
with ethidium bromide (0.25mgml
 1).
Real-time PCR analysis
We have developed and established a reliable TaqMan-PCR assay
for the quantification of the 3895bp deletion. The quantitative
TaqMan-PCR method provides real-time measurement of target
input as PCR accumulation through a dual labelled probe. The
probe anneals between forward and reverse primers and it is
Table 1 Oligonucleotide primers used to detect the 3895bp deletion in the standard and real-time PCR assays
Name Dye Position Sequence
ISF 16042-16066 50-GAT TTG GGT ACC ACC CAA GTA TTG-30
ISR 16125-16102 50-AAT ATT CAT GGT GGC TGG CAG TA-30
IS-Probe Vic 16069-16101 50-CAC CCA TCA ACA ACC GCT ATG TAT TTC GTA CA-30Tamra
3895F 491-508 50-CAA CCC TCG CCC ATC CTA-30
3895R 4516-4489 50-CCT GCA AAG ATG GTA GAG TAG ATG AC-30
3895-probe Fam 527//4450 50-TGC TAA CCC CAT ACC CCG AAA ATG TTG G-30Tamra
L404 404-423 50-CTT TTG GCG GTA TGC ACT TT-30
H4676 4676-4657 50-GAT TAT GGA TGC GGT TGC TT-30
3895 bp Deletion
ISR
IS-probe
ISF 
3895F
3895-Probe
3895R 
0/16 569
mtDNA
H4676 
L404
Figure 1 Localisation of PCR primers and TaqMan probes. Schematic
representation of the mtDNA genome containing the 3895bp deletion.
Primers ISF/ISR and IS Probe, anneals to both wild-type and deleted
mtDNA. Detection of the 3895bp deletion was performed with primers
3895F/3895R and 3895 Probe. The specific 3895 Probe only anneals to
deleted mtDNA as it binds across the deletion junction. In addition, the
occurence of the 3895bp deletion brings together the deletion specific
primers (i.e. 3895F:3895R and L404:H4676) close enough to allow
generation of an amplicon under the given PCR conditions. The deleted
region includes the mtTF1 binding site in the D-loop to tRNA methionine
and deleted genes include 12s rRNA, 16s rRNA, ND1 as well as the
promoters for transcription of both the H and L strands.
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scleaved by the 50–30 exonuclease activity of Taq polymerase during
the PCR extension phase. Therefore, the 50-terminal reporter dye
FAM (6-carboxyfluorescein) or VIC and the 30-terminal quencher
dye TAMRA (6-carboxy-N,N,N0,N0-tetramethylrhodamine) linked to
the probe are separated, resulting in a fluorescence emission of the
reporter dye. The probe is not able to serve as a primer itself because
it is 30-terminally blocked with a phosphate group. The method uses
an internal standard probe (IS-Probe, Table 1 and Figure 1) in the
cytochrome b region of the genome (Koch et al, 2001), to estimate
total copy number for mtDNA (i.e. deleted and wild type). The level
of 3895bp deletion is determined by a probe (3895-probe, Table 1
and Figure 1) which spans the break point of the deletion ensuring
that it is only amplified if the deletion is present. Quantification of
the level of deletion is determined by comparison of the ratio of the
internal standard to the 3895bp deletion.
Amplification reactions were performed as 25ml triplicates in a
96-well microplate. Total mtDNA and deleted mtDNA reactions
were amplified in separate tubes, each containing 100ng of DNA,
1  TaqMan Universal Mastermix (ABI), 300nM of each internal
standard primer (ISF and ISR, Table 1 and Figure 1) and 100nM of
the IS-Probe, or 300nM of each 3895bp deletion primer (3895F and
3895R, Table 1) and 100nM of the 3895-probe (Figure 1). PCR and
fluorescence analysis was performed using a ABI Prism 7000
(Applied Biosystems, UK). Amplification conditions were: 2min at
501C, 10min at 951C followed by 40 cycles of 15s at 951C and 1min
at 601C. The Rn value is the ratio of the emission intensity of the
passive reference, a dye included in the TaqMan reaction buffer.
DRn is defined as the difference between Rn
þ (Rn of a reaction
containing all the components including template) and Rn
  (Rn of a
no template control). The cycle at which a statistically significant
increase in DRn is detected first is called the threshold cycle (Ct).
Fluorescence signals are regarded as significant if the fluorescent
intensity exceeds 10-fold the s.d. of the background Rn value to
define a threshold.
Absolute DNA quantification was performed using the standard
curve method. Reactions were carried out with different concen-
trations of two standard plasmids (for cloning see section below)
in parallel to the samples that should be quantified. The standard
plasmids, one carrying sequences flanking the 3895bp deletion
(i.e. the region covered by the 3895F and R primers) and one
carrying a unique sequence of the mtDNA independent of the
3895bp deletion (i.e. the region covered by the ISF and R primers),
allowed the generation of two standard curves showing the number
of copies of total mtDNA or mtDNA harbouring the 3895bp
deletion vs the measured Ct. The Ct values of samples could then
easily be converted to the number of DNA copies by comparing Ct
for the sample to the Ct for the respective standard plasmid of
known concentrations. The concentration of each template was
determined fluorometrically (Turner Biosytems, UK). The amount
of mutation corresponds to the ratio of mtDNA with the 3895bp
deletion to wild-type mtDNA within each sample. If not detected
within 40 cycles (Ct¼40), DNA is considered absent. Ct 436 and
o40 represent measured data, but for absolute quantification only
values of Ct p36 were used for reasons of reliability.
TOPO TA cloning
All cloning was carried out using a TOPO TA Cloning kit
(Invitrogen, UK) according to the manufacturers instructions. TOPO
TA cloning takes advantage of the nontemplate-dependent terminal
transferase activity of Taq polymerase that adds a single deoxyade-
nosine (A) to the 30ends of PCR products. The linearised vector
supplied with the kit has a single, overhanging 30deoxythymidine (T)
residue, allowing efficient ligation between PCR product and vector.
The presence of an insert of the correct size was confirmed by EcoRI
restriction fragment analysis in the vector pCR4-TOPO.
RESULTS
Development of a real-time PCR assay for the
quantification of the 3895bp deletion
We first determined whether it was possible to reliably detect and
quantify the percentage of copies of the mitochondrial genome
harbouring the 3895bp mtDNA deletion. We, therefore, examined
the linearity of the two PCR reactions using either the internal
3895 FAM/TAMRA
y = 1.46 Ln(x) + 7.6121
R2 = 0.9952
y = 1.4254 Ln(x) + 9.9099
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Figure 2 Sensitivity of real-time PCR to template copy number. Threshold cycle (i.e. Ct, vertical axis) at decreasing concentrations of template DNA
(horizontal axis) for the 3895bp deletion (A) or wild type internal standard (B) are shown. There is a linear relationship between template concentration
and the threshold cycle number (Ct) for both amplifications. Each number represents the mean 7s.d. for three independent observations.
A quantitative marker for sunlight exposure in human skin
A Harbottle and MA Birch-Machin
1889
British Journal of Cancer (2006) 94(12), 1887–1893 & 2006 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sstandard probe (IS-probe, Figure 1) or the 3895bp deletion probe
(3895-probe, Figure 1) over a wide range of template concentra-
tions. In both cases, we generated template DNA by cloning the
appropriate PCR product into a cloning vector (see Materials and
Methods). The real-time PCR amplifications were performed using
serial dilutions of DNA encompassing between 50ng and 50pg of
template DNA for each probe (Figure 2). The relationship between
the Ct value and the template concentration was linear for both the
3895bp deletion (r¼0.9952, Figure 2A) and the internal standard
(r¼0.9941, Figure 2B). In addition, the gradient for amplification
of each template was the same for both the 3895bp deletion and
the internal standard cloned templates. Importantly, this confirms
that each template is amplified to the same degree of efficiency. As
a result, the Ct values can therefore be used as a measure of
template DNA and to quantify the relative amount of 3895bp
deletion compared to wild-type mtDNA. Furthermore, the ability
of these standard curves to accurately predict the ratio of deleted:
wild-type mtDNA was confirmed by using a range of the cloned
deleted:wild-type template mixtures from 0 to 100% (results not
shown).
Quantification of the 3895bp deletion in tumours
Previous investigations of the 3895bp deletion in NMSC have been
limited to a brief single study of a small number of samples using a
standard nonquantitative PCR assay which provides simple data
such as the presence or absence of the deletion (Krishnan et al,
2004). In our current investigations, we now determine the level of
the 3895bp deletion within human skin taken from NMSCs and the
corresponding histologically normal perilesional dermis and
epidermis using the developed real-time Taqman PCR assay
described above. These results were then compared to the data
obtained by analysing the same samples using the previously
established standard PCR assay and ethidium bromide stained gels
(Krishnan et al, 2004).
The results of this comparison show that the levels of the
3895bp deletion quantified by real-time PCR were generally in
concordance with those estimated by the standard nonquantitative
PCR analysis (Figure 3). The simple pattern of occurrence of the
3895bp deletion in BCCs was generally similar to that observed in
SCCs. In the tumour samples the deletion was present in three of
five of both BCC and SCC patients (although not the same
patients). In the perilesional skin the deletion tended to occur
more frequently in the dermis of the BCC samples (four of five)
compared to the epidermis (two of five) although the number of
samples was not sufficient for meaningful statistical analysis.
However, although the absolute number of samples is small, there
is additional valuable information provided by the actual level of
the deletion as determined by the real-time PCR assay rather than
its simple pattern of occurrence as determined by the standard
nonquantitative PCR analysis. For example in both the SCC and
BCC patients, the level of the deletion in the dermis was higher
than its corresponding epidermal sample. In addition, it was
interesting to observe that BCC samples taken from two distinct
areas of the face showed vastly different levels of the deletion (i.e.
7.14 vs 0.02%), which may reflect variation in the degree of
cumulative sun exposure with body site. We decided to investigate
this aspect further by determining the level, as opposed to the
pattern of occurrence, of the deletion in a relatively large subset of
histologically normal perilesional skin samples taken from
different sun-exposed human body sites.
Quantification of the 3895bp deletion in a larger subset of
histologically normal perilesional skin samples taken from
different sun-exposed body sites
Histologically normal perilesional skin, rather than tumour
samples were chosen so as to avoid confounding factors other
than the site of cumulative sun exposure. We investigated the
3895bp deletion in 104 age-matched split human skin samples
taken from various sun-exposed sites defined as usually exposed
(n¼60) and occasionally exposed (n¼44) when outdoors
(Armstrong, 2004). According to this definition body sites which
are ‘usually’ exposed to the sun when outdoors include the scalp,
face, neck and ears while those which are ‘occasionally’ exposed to
the sun include shoulders, back and chest. Figure 4 shows a
representative comparison of results from three pairs of usually
and occasionally sun-exposed samples using both the quantitative
real-time PCR assay compared with the standard nonquantitative
PCR assay (i.e. ethidium bromide stained agarose gel of the
3895bp amplicon). A comparison of the levels of the 3895bp
deletion detected by real-time PCR with those detected by standard
PCR showed once again a good correlation between the two PCR
assays. We, therefore, decided to analyse all the samples using the
quantitative real-time PCR assay. The results from this analysis
(Figure 5) clearly showed an increased incidence of the 3895bp
deletion with increasing sun exposure. In specific terms, the
quantitative real-time PCR analysis showed a significantly higher
level of the deletion in the usually sun-exposed samples when
compared to the occasionally sun-exposed samples (P¼0.0009 for
dermis, P¼0.008 for epidermis; two-tailed t-test). Interestingly,
the dermal samples harboured a higher level of the deletion than
BCCs
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Figure 3 Real-time PCR quantification and standard PCR amplification
of the 3895bp deletion in tumours. Ethidium bromide stained agarose gel
showing the incidence of the 3895bp deletion in tumour (T) and
histologically normal perilesional dermis (D) and epidermis (E) from both
BCCs (A) and SCCs (B) using the standard PCR assay. There are two
different tumour samples (T1 and T2) from patient 1 (A); the associated
dermis and epidermis are taken perilesional to T1. Below each lane is
shown the level of the 3895bp deletion illustrated as a percentage in each
sample as quantified by real-time taqman PCR. Those samples marked with
nd are determined to be effectively zero or ‘not detectable’ as the Ct of the
real-time PCR was 436, which is the level observed in the no template
control. Lane 1 in all panels¼molecular weight markers (Hyperladder IV –
range 1000–100bp, Bioline Ltd, London UK). The positive (þ) control in
(B) is the tumour DNA from which the PCR product was cloned and
sequenced to produce the template for real-time PCR. The same amount
of template DNA was added to each PCR reaction. It worth noting that the
greater sensitivity of the real-time PCR assay compared to the standard
PCR assay is shown by the fact that detectable levels of the deletion are
observed with the real-time assay even though there are no detectable
PCR amplicons on the ethidium stained gel.
A quantitative marker for sunlight exposure in human skin
A Harbottle and MA Birch-Machin
1890
British Journal of Cancer (2006) 94(12), 1887–1893 & 2006 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sthe epidermis (P¼0.0143 occasionally exposed, P¼0.0007 usually
exposed).
DISCUSSION
The level of the 3895bp deletion is higher in samples from
usually compared to occasionally sun-exposed skin
Previous work by ourselves and others have shown a UVR-
associated increase in the incidence of the mtDNA damage in sun-
exposed compared to rarely sun-exposed human skin when
outdoors. The major limitation of these studies is their failure to
address the fact that sun-exposed body sites are divided into two
distinct categories, usually (i.e. face and hands) and occasionally
(i.e. trunk and legs) (Armstrong, 2004). This is vitally important
for skin cancer research as the vast majority of NMSCs occur on
usually sun-exposed sites. Previous findings have shown that the
frequency of occurrence (i.e. the simple presence or absence) of
the 3895bp deletion is increased with increasing sun exposure
(Harbottle et al, 2004; Krishnan et al, 2004). Our present study has
extended this work because it has used a quantitative real-time
PCR assay to investigate the actual level of the 3895bp in different
sun-exposed body sites. The results from this analysis clearly
showed an increased incidence of the 3895bp deletion with
increasing sun exposure. In specific terms, the quantitative real-
time PCR analysis showed a significantly higher level of the
deletion in the usually sun-exposed samples when compared to the
occasionally sun-exposed samples (P¼0.0009 for dermis,
P¼0.008 for epidermis; two-tailed t-test). The mean ages, sex
ratios and tumour type from which the perilesional skin was taken
were very similar between the usually sun-exposed and occasion-
ally exposed groups (see Materials and methods) which implies
that our findings are unlikely to be confounded by these factors.
Functional significance
The regions that are deleted in the 3895bp deletion are from the
mtTF1-binding site in the D-loop to tRNA methionine. Deleted
genes include 12s rRNA, 16s rRNA, ND1 and also the promoters
for transcription of both the H and L strands. The 3895bp deletion
levels observed in this study are up to 2% in the sun-exposed skin
samples and 7% in the NMSC samples and therefore may have a
partial deficiency effect on oxidative phosphorylation. It is known
in human muscle that individual fibers can differ in their level of
mtDNA deficiency throughout the muscle and that these differing
levels will contribute to an overall average of mtDNA deficiency in
a given muscle sample (Brierley et al, 1998). Therefore, it is more
likely that the levels observed in skin represent an overall average
and that individual cells and/or focal areas will have several fold
higher and lower areas of damage throughout the sample. This
may result in a deficiency of oxidative phosphorylation in these
focal areas. This scenario is further complicated by the recessive
nature of mtDNA (Chomyn et al, 1992; Sciacco et al, 1994), the
threshold of mtDNA damage which is required to cause a
biochemical consequence (Porteous et al, 1998) and the capacity
of mtDNA to harbour a high mutation load. At the tissue rather
than the cellular level, these effects can also be dependent on the
energetic capacity of the tissue as there is a higher proportion of
mitochondria in tissues with high energy demands. The resultant
effect in skin, however, is uncertain at present and may be related
to the different energetic demands in the differentiating epidermis
compared to the dermis.
Putative mechanism
It has been previously suggested that the mechanism for the
generation of the 4977bp deletion involves a intragenomic
recombination event via slipped strand mispairing which may
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Figure 4 Real-time PCR quantification and standard PCR amplification
of the 3895bp deletion in usually sun-exposed and occasionally sun-
exposed skin. Representative ethidium bromide agarose gels showing
typical examples of the frequency of occurrence of the 3895bp deletion as
determined by the standard PCR assay in three pairs of usually (A) and
occasionally (B) sun-exposed samples. Below each lane is shown the level
of the 3895bp deletion illustrated as a percentage in each sample as
quantified by real-time Taqman PCR. Lane 1 in both panels¼molecular
weight markers (Hyperladder IV – range 1000–100bp, Bioline Ltd, London
UK). The same amount of template DNA was added to each PCR reaction.
The positive control (þ) in both panels is the tumour DNA from which
the PCR product was cloned and sequenced to produce the template for
real-time PCR. Those samples marked with nd are determined to be
effectively zero or ‘not detectable’ as the Ct of the real-time PCR was 436,
which is the level observed in the no template control.
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Figure 5 Quantification of the 3895bp deletion in usually and
occasionally sun-exposed human skin. Scatter plot showing the levels of
the 3895bp deletion expressed as a percentage of wild-type mtDNA in
usually and occasionally sun-exposed dermis (D) and epidermis (E), as
determined by real-time Taqman PCR. The mean level of deletion is
indicated by a horizontal line for each set of samples.
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soccur at the 13bp repeats flanking the deletion (Schon et al, 1989;
Shoffner et al, 1989; Mita et al, 1990; Degoul et al, 1991). This
mechanism requires that regions on both the heavy and light
mtDNA strands are simultaneously single-stranded. However,
neither of the 13bp repeats are single-stranded in a simultaneous
event during replication (Schon et al, 1989). Schon et al, also
suggested that homopyrimidine regions in the 13bp repeat/or
flanking AT-rich regions may be susceptible to DNA bending that
would ‘open up’ a small region or ‘bubble’ of single-stranded DNA.
Interestingly, these homopyrimidine regions map to structurally
labile ‘hot regions’ for the 4977bp common deletion that assume
an unusual bent-DNA structure and may therefore enhance the
intragenomic recombination event (Hou and Wei, 1998). The
results in our current study and our previous work (Harbottle
et al, 2004; Krishnan et al, 2004) suggest strongly that UVR is a
contributing factor in the generation of the 3895bp deletion.
Furthermore, we know that the 3895bp deletion is flanked by 12bp
repeats. It is therefore tempting to propose that the generation of
the 3895bp deletion may occur by a similar mechanism to the
proposed model for the 4977bp common deletion. Therefore, one
might suggest that prolonged UVR exposure could either directly
(by inducing base substitutions as opposed to deletions) or
indirectly (by induction of free radicals) affect these 12bp repeat
structurally labile sites through opening a ‘bubble’ of single-
stranded DNA that would enhance the recombination event,
thereby eliciting an increase in mtDNA deletions. In this respect, it
is of interest to note that investigation of the 3895bp deletion in
the same NMSC samples (Krishnan et al, 2004) which were used in
a previous study of the 4977bp common deletion (Durham et al,
2003), showed a comparatively greater frequency of occurrence of
the 3895bp deletion. As these tumours were excised from body
sites that are usually exposed to the sun, it is interesting to
speculate that the 3895bp deletion may be a more sensitive marker
of cumulative sun exposure than the 4977bp common deletion.
The dermis harbours a higher level of the 3895bp deletion
than the epidermis
Our study has also extended previous findings (Birch-Machin et al,
1998; Ray et al, 2000; Krishnan et al, 2004) by showing that the
level rather than simply the frequency of occurrence of the 3895bp
deletion is significantly higher in the dermis compared with
the epidermis both in the occasionally sun-exposed samples
(P¼0.0143) and in the usually sun-exposed skin (P¼0.0007). This
observation was confirmed by the results of the real-time PCR
analysis of the tumours and the corresponding perilesional skin
(i.e. dermis and epidermis) from the NMSC patients. Initially, this
observation would seem unexpected as the epidermis, being the
upper layer of the skin, receives a higher total proportion of UVR
and also acts as a filter of UVR for the dermis. However, based on
evidence from previous studies in several tissues (Ikebe et al, 1990;
Corral-Debrinski et al, 1991; Lee et al, 1994), it has been proposed
(Cortopassi et al, 1992) that there is often more mtDNA damage
(particularly deletions, although the 3895bp is not specifically
mentioned) in tissues that turn over slowly or not at all (e.g. brain
and muscle) than in those that turn over relatively more rapidly
(e.g. liver and blood cells). Mitochondria harbouring mutant
mtDNA will of course suffer a disadvantage during the energy
consuming process of replication (Kowald, 1999). This effect will
be highest in rapidly dividing cells and so the high turnover of
keratinocytes may give little time for accumulation of mtDNA
deletions. In contrast the low proliferative rate of fibroblasts may
give more opportunity for the accumulation of deleted mtDNA.
Furthermore the higher activity of antioxidant enzymes such as
superoxide dismutase and catalase in the epidermis compared with
the dermis (Shindo et al, 1994) would contribute to the decreased
mutational load observed in the epidermis. In addition, it worth
noting that it is the longer UV wavelengths that penetrate to the
dermis and may therefore contribute to the damage possibly
through photosensitisation and singlet oxygen production (Birch-
Machin, 2006) rather than directly by UV-induced photoproducts
such as pyrimidine dimers or six to four photoproducts. The
deletion-junction sequence that is characteristic of the 3895bp
deletion is 50 CTAACC
536bp/4430bpccataccccgaa
548bp/4442AATGTT
30. Characteristically this sequence contains only one of the two
12bp repeats that flank the 3895bp deletion in wild-type mtDNA
(lower case letters). It is clear, however, that the repeat sequence
harbours adjacent pyrimidines for possible photoproduct forma-
tion. As these repeat regions are structurally labile, it is possible
that the deletion occurs as a result of a combination of direct
induction of photoproducts coupled with oxidative stress, the
relative contribution of these effects may be associated with skin
depth and hence UVR penetration.
Concluding remarks
In summary, our present study has extended previous work by
developing and then using a quantitative real-time PCR assay to
investigate for the first time the actual level (as opposed to the
freqeuncy of occurrence) of the 3895bp deletion in human skin
from different sun-exposed body sites and tumours from NMSC
patients. The results from this analysis clearly show an increased
level of the 3895bp deletion with increasing sun exposure. In
specific terms, the quantitative real-time PCR analysis showed a
significantly higher level of the deletion in the usually sun-exposed
samples when compared to the occasionally sun-exposed skin. Our
study has also extended previous findings by showing that the level
rather than simply the frequency of occurrence of the 3895bp
deletion is significantly higher in the dermis compared with the
epidermis both in the occasionally sun-exposed and in the usually
sun-exposed skin samples. The determination of the actual level of
the 3895bp deletion provides an opportunity to investigate several
research areas. For example, it provides a method for studying the
association between the actual level of the mutational load and
tumour progression including the involvement of precursor
lesions. In addition, through the use of laser capture microscopy
it would be possible to determine the actual level of mtDNA
damage within focal areas found in different layers of the skin. As a
final example, a reliable real-time PCR assay for the 3895bp
deletion will provide a means of comparing the relative amounts of
the 3895bp and 4977bp common mtDNA deletion within the same
skin sample and help to provide some clues as to the aetiology of
the two types of mtDNA damage in relation to sun exposure.
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